A large, peer-reviewed study published Friday in JAMA Network Open found that transgender youths prescribed puberty blockers had significantly lower adjusted odds of diagnosed mood disorders and suicidal thoughts and behaviors than transgender youths who did not receive the medications, adding new evidence to one of the most politically contentious areas of pediatric medicine.
The nationwide retrospective cohort study examined insurance claims data from more than 231,000 youths between 2016 and 2025, comparing transgender and cisgender youths who either did or did not receive puberty blockers.
They’ll just dismiss this the same way they do with every mental health association study, it’s not placebo controlled.
Same thing they did with psychedelic studies, then when they did placebo controlled studies they claimed those weren’t valid because the rather obvious side effects make blinding both pointless and impossible.